The store will not work correctly when cookies are disabled.
(S)-3-Hydroxy-2-oxo-1-phenylpyrrolidine-3-carboxylic Acid (2-Thiophen-2-ylethyl)amide
ID: ALA4566670
PubChem CID: 56959820
Max Phase: Preclinical
Molecular Formula: C17H18N2O3S
Molecular Weight: 330.41
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(NCCc1cccs1)[C@@]1(O)CCN(c2ccccc2)C1=O
Standard InChI: InChI=1S/C17H18N2O3S/c20-15(18-10-8-14-7-4-12-23-14)17(22)9-11-19(16(17)21)13-5-2-1-3-6-13/h1-7,12,22H,8-11H2,(H,18,20)/t17-/m0/s1
Standard InChI Key: FZATYXICMFSLHR-KRWDZBQOSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
11.0327 -3.2956 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.8327 -3.5124 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6204 -2.7112 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5480 -6.0205 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5468 -6.8478 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2616 -7.2606 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9779 -6.8473 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9751 -6.0168 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2598 -5.6077 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2514 -4.7818 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.9174 -4.2949 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6601 -3.5111 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5826 -4.2990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7988 -4.5563 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.2053 -2.1294 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.8241 -2.4956 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.0015 -2.3451 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5864 -1.7633 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3827 -1.9790 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6804 -2.7482 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
15.5043 -2.7072 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7200 -1.9109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0293 -1.4598 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
2 3 1 1
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
10 11 1 0
11 12 1 0
12 2 1 0
2 13 1 0
13 10 1 0
9 10 1 0
13 14 2 0
3 15 1 0
3 16 2 0
15 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 2 0
22 23 1 0
23 19 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 330.41 | Molecular Weight (Monoisotopic): 330.1038 | AlogP: 1.57 | #Rotatable Bonds: 5 |
Polar Surface Area: 69.64 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.77 | CX Basic pKa: ┄ | CX LogP: 1.56 | CX LogD: 1.56 |
Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.82 | Np Likeness Score: -1.24 |
References
1. Heinrich T, Seenisamy J, Blume B, Bomke J, Calderini M, Eckert U, Friese-Hamim M, Kohl R, Lehmann M, Leuthner B, Musil D, Rohdich F, Zenke FT.. (2019) Discovery and Structure-Based Optimization of Next-Generation Reversible Methionine Aminopeptidase-2 (MetAP-2) Inhibitors., 62 (10): [PMID:30939017] [10.1021/acs.jmedchem.9b00041] |